Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;184(5):796-798.
doi: 10.1111/bjd.19712. Epub 2021 Jan 4.

A growing family of outcome measurement proposals for hidradenitis suppurativa

Affiliations
Comment

A growing family of outcome measurement proposals for hidradenitis suppurativa

L Emtestam et al. Br J Dermatol. 2021 May.

Abstract

Linked Article: Goldfarb et al. Br J Dermatol 2021; 184:905–912.

PubMed Disclaimer

Comment on

References

    1. Zouboulis CC, Desai N, Emtestam L et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29:619–44. - PubMed
    1. Kimball AB, Okun MM, Williams DA et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med 2016; 375:422–34. - PubMed
    1. Thorlacius L, Ingram JR, Villumsen B et al. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process. Br J Dermatol 2018; 179:642–50. - PMC - PubMed
    1. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and benign familial pemphigus. Surgical approach. In: Dermatologic Surgery. Principles and Practice (Roenigk RK, Roenigk HH, eds), 2nd edn. New York: Marcel Dekker, 1996; 623–45.
    1. Goldfarb N, Lowes MA, Butt M et al. Hidradenitis Suppurativa Area and Severity Index Revised (HASI‐R): psychometric property assessment. Br J Dermatol 2021; 10.1111/bjd.19565. - DOI - PMC - PubMed